If Stephen Quake gets his way, biologists in the future will spend a lot less time wielding pipettes. “Our goal,” he says, ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Current Biology is a scientific journal that covers all areas of biology, especially molecular biology, cell biology, genetics, neurobiology, ecology and evolutionary biology. The journal is ...

Read the latest science news from Phys.org on biology, evolution, microbiology, biotechnology ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

Plant fossils were found in the abdomen of a dinosaur called a sauropod, shown in this artistic impression. Image credit: ...

June 6, 2025 Knoepfler is professor of cell biology and human anatomy at UC Davis School of Medicine. Welcome to Lab Dish, a First Opinion column on regenerative medicine from Paul Knoepfler.

Abstract Or101: Effects of pathogenic variation in ADAMTSL4 on vascular smooth muscle cell function relevant to spontaneous coronary artery dissection Cameron Pinnock, BS, MSE, PhD, Kristina Hunker, ...

Mammalian caspases are a group of cysteine proteases historically categorized into an ‘inflammatory’ subgroup and an ‘apoptotic’ subgroup, although accumulating evidence indicates that ...

New data from the BEACON trial with more patients and longer follow-up provide further demonstration of the strong clinical profile for the investigational base-editing therapy BEAM-101, as ...

With more than 4,000 cell, gene, and RNA therapies in development, Cannon said, that is “a very big iceberg.” Charles Gersbach, PhD, a co-founder of Tune Therapeutics, discussed the potential ...